Repositori URV

Identificador: imarina:6390432

Handle: https://hdl.handle.net/20.500.11797/imarina6390432

Autores:
Pelletier, JoffreyRiano-Canalias, FerranAlmacellas, EugeniaMauvezin, CarolineSamino, SaraFeu, SoniaMenoyo, SandraDomostegui, AnaGarcia-Cajide, MartaSalazar, RamonCortes, ConstanzaMarcos, RicardTauler, AlbertYanes, OscarAgell, NeusKozma, Sara CGentilella, AntonioThomas, George

Resumen:
©2020 The Authors. Published under the terms of the CC BY 4.0 license Many oncogenes enhance nucleotide usage to increase ribosome content, DNA replication, and cell proliferation, but in parallel trigger p53 activation. Both the impaired ribosome biogenesis checkpoint (IRBC) and the DNA damage response (DDR) have been implicated in p53 activation following nucleotide depletion. However, it is difficult to reconcile the two checkpoints operating together, as the IRBC induces p21-mediated G1 arrest, whereas the DDR requires that cells enter S phase. Gradual inhibition of inosine monophosphate dehydrogenase (IMPDH), an enzyme required for de novo GMP synthesis, reveals a hierarchical organization of these two checkpoints. We find that the IRBC is the primary nucleotide sensor, but increased IMPDH inhibition leads to p21 degradation, compromising IRBC-mediated G1 arrest and allowing S phase entry and DDR activation. Disruption of the IRBC alone is sufficient to elicit the DDR, which is strongly enhanced by IMPDH inhibition, suggesting that the IRBC acts as a barrier against genomic instability.